Search Results 821-830 of 10166 for SC
Balasubramaniam SC, Raja H, Nau CB, Shen JF, Schornack MM. Ocular Graft-Versus-Host Disease: A Review. Eye Contact Lens. 2015 Sep; 41: (5)256-61. View ...
Inability to tolerate SC medication;; Inability to tolerate venipuncture;; Women who are breastfeeding. Prior and concomitant therapy: Participants who have ...
This medical emergency involves sudden loss of all heart activity. Learn how fast, appropriate care may help prevent death.
the investigator, would allow SC injection at the abdomen or the front, middle region of the thigh. 9. Participant is capable and willing to self-administer ...
Sc. Scalacort. Also known as. Hydrocortisone (topical application route). Scalpcort. Also known as. Hydrocortisone (topical application route). Scemblix. Also ...
The purpose of this study is to assess the patient's preference for nivolumab subcutaneous (SC) or nivolumab + relatlimab fixed-dose combination (FDC) SC and ...
Cabrera DT, Bellolio MF, Poblete RU, Alvizu SC, Laack T, Saldias FP. [Emergency medicine clinical series. Oncologic emergencies. Approach to the patient ...
Navada SC. Shyamala C; Silverman LR. Lewis R. Expert review of anticancer therapy. 2016. Aug; 16(8):805-10. Hypomethylating agents (HMAs) are the standard of ...
... SC. Predictors of Local Control With Palliative Radiotherapy for Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2025 Mar; 25 (3):212-218 Epub 2024 Oct 05
The purpose of this trial is to evaluate the effectiveness, safety, and tolerability of subcutaneous (s.c.) ianalumab given every 4 weeks (q4w) or every 12 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.